Normal range | Before procedure | The sixth day after the procedure | ||
---|---|---|---|---|
Complete blood count | ||||
White blood cells | × 102/ μL | 30–97 | 40 | 291 |
Neutrophils | % | 36.6–79.9 | 70.1 | 92 |
Hemoglobin | g/dL | 13.1–17.6 | 9.3 | 5.1 |
Platelet counts | × 104/ μL | 12.4–30.5 | 11.6 | 11.4 |
Biochemistry | ||||
Total bilirubin | mg/dL | 0.1–1.2 | 0.7 | 14 |
Aspartate aminotransferase | IU/L | 12–35 | 33 | 1300 |
Alanine aminotransferase | IU/L | 6–40 | 76 | 362 |
Lactate dehydrogenase | IU/L | 119–229 | 235 | 4523 |
γ-glutamyl transpeptidase | IU/L | 0–48 | 82 | 108 |
Alkaline phosphatase | IU/L | 115–359 | 427 | 751 |
Blood-urea-nitrogen | mg/dL | 7.4–19.5 | 32.8 | 45.9 |
Creatinine | mg/dL | 0.5–1.2 | 1.35 | 1.50 |
Total protein | g/dL | 6.4–8.3 | 6.7 | 6.0 |
Albumin | g/dL | 3.8–5.2 | 3.2 | 2.4 |
Sodium | mEq/L | 135–147 | 140 | 132 |
Potassium | mEq/L | 3.4–4.8 | 4.1 | 4.7 |
Ammonia | μg/dL | 12–66 | 102 | 145 |
HbA1c | % | 4.6–6.2 | 5.5 | |
Coagulation | ||||
PT-INR | 0.89–1.12 | 1.04 | 1.58 | |
APTT | seconds | 23.6–31.3 | 22.9 | 44.1 |
Tumor marker | ||||
Alpha-fetoprotein | ng/mL | 0–10 | 36,690 | |
PIVKA-II | mAU/mL | 0–39 | 3743 | |
Serology | ||||
Hepatitis B surface antigen | negative | |||
Hepatitis C virus antibody | negative |